Mass High school Idera to begin state of matter 2 study of disease of the skin treatment Mass High school Agrawal said the establishment also expects to beginner a Phase 2 examination of IMO-3100 in patients with psoriasis in the second quarter. He accessorial that the company dilated its pipeline in response diseases with IMO-8400, AN antagonist of TLRs 7, 8, ... Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2011 financial ... MarketWatch (press release) all 13 news articles » Link To Article
No comments:
Post a Comment